首页> 美国卫生研究院文献>Wiley-Blackwell Online Open >Concise Review: Mesenchymal Stem Cell Treatment of the Complications of Diabetes Mellitus
【2h】

Concise Review: Mesenchymal Stem Cell Treatment of the Complications of Diabetes Mellitus

机译:简要评论:间充质干细胞治疗糖尿病并发症

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Mesenchymal stem cells (MSCs) are multipotent, self-renewing cells that can be found in almost all postnatal organs and tissues. The main functional characteristics of MSCs are their immunomodulatory ability, capacity for self-renewal, and differentiation into mesodermal tissues. The ability of MSCs to differentiate into several cell types, including muscle, brain, vascular, skin, cartilage, and bone cells, makes them attractive as therapeutic agents for a number of diseases including complications of diabetes mellitus. We review here the potential of MSCs as new therapeutic agents in the treatment of diabetic cardiomyopathy, diabetic nephropathy, diabetic polyneuropathy, diabetic retinopathy, and diabetic wounds. Also, in this review we discuss the current limitations for MSCs therapy in humans. Stem Cells 2011;29:5–10
机译:间充质干细胞(MSC)是多能的自我更新细胞,几乎可以在所有产后器官和组织中找到。 MSC的主要功能特征是其免疫调节能力,自我更新能力和分化为中胚层组织。 MSCs分化为几种细胞类型的能力,包括肌肉,大脑,血管,皮肤,软骨和骨细胞,使其成为许多疾病的治疗剂,包括糖尿病并发症。我们在这里回顾了MSCs作为新型治疗剂在糖尿病性心肌病,糖尿病性肾病,糖尿病多发性神经病,糖尿病性视网膜病和糖尿病伤口治疗中的潜力。另外,在本综述中,我们讨论了人类MSC治疗的当前局限性。干细胞2011; 29:5-10

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号